Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective.
This editorial discusses the recent European Society for Human Reproduction and Embryology/American Society for Reproductive Medicine recommendations on the treatment of infertility in polycystic ovarian syndrome. Evidence is provided for the use of metformin in selected patients.
John E
JE
Nestler
D002996:Clomiphene / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D050498:Live Birth; D008687:Metformin / Q000008:administration & dosage / Q000627:therapeutic use*; D010060:Ovulation / Q000187:drug effects*; D010062:Ovulation Induction / Q000379:methods*; D018579:Patient Selection; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D018873:Pregnancy Rate; D016896:Treatment Outcome
D005300:Fertility Agents, Female; D002996:Clomiphene; D008687:Metformin